Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management

被引:184
作者
Arroyo, V [1 ]
Colmenero, J [1 ]
机构
[1] Univ Barcelona, Hosp Clin, Inst Digest Dis, Liver Unit, E-08036 Barcelona, Spain
关键词
D O I
10.1016/S0168-8278(03)00007-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S69 / S89
页数:21
相关论文
共 250 条
[1]   TREATMENT OF HEPATORENAL-SYNDROME WITH THE TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT (TIPS) [J].
ALAM, I ;
BASS, NM ;
LABERGE, JM ;
RING, EJ ;
SOMBERG, KA .
GASTROENTEROLOGY, 1995, 108 (04) :A1024-A1024
[2]   VASODILATATION AND SODIUM RETENTION IN PREHEPATIC PORTAL-HYPERTENSION [J].
ALBILLOS, A ;
COLOMBATO, LA ;
GROSZMANN, RJ .
GASTROENTEROLOGY, 1992, 102 (03) :931-935
[3]   CONTINUOUS PRAZOSIN ADMINISTRATION IN CIRRHOTIC-PATIENTS - EFFECTS ON PORTAL HEMODYNAMICS AND ON LIVER AND RENAL-FUNCTION [J].
ALBILLOS, A ;
LLEDO, JL ;
ROSSI, I ;
PEREZPARAMO, M ;
TABUENCA, MJ ;
BANARES, R ;
IBORRA, J ;
GARRIDO, A ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1995, 109 (04) :1257-1265
[4]   ORAL-ADMINISTRATION OF CLONIDINE IN PATIENTS WITH ALCOHOLIC CIRRHOSIS - HEMODYNAMIC AND LIVER-FUNCTION EFFECTS [J].
ALBILLOS, A ;
BANARES, R ;
BARRIOS, C ;
CLEMENTE, G ;
ROSSI, I ;
ESCARTIN, P ;
BOSCH, J .
GASTROENTEROLOGY, 1992, 102 (01) :248-254
[5]   5-fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]benzamide (VPA-985):: An orally active arginine vasopressin antagonist with selectivity for V2 receptors [J].
Albright, JD ;
Reich, MF ;
Delos Santos, EG ;
Dusza, JP ;
Sum, FW ;
Venkatesan, AM ;
Coupet, J ;
Chan, PS ;
Ru, X ;
Mazandarani, H ;
Bailey, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (14) :2442-2444
[6]   Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].
Angeli, P ;
Volpin, R ;
Gerunda, G ;
Craighero, R ;
Rone, P ;
Merenda, R ;
Amodio, P ;
Sticca, A ;
Caregaro, L ;
Maffei-Faccioli, A ;
Gatta, A .
HEPATOLOGY, 1999, 29 (06) :1690-1697
[7]   RENAL EFFECTS OF NATRIURETIC PEPTIDE RECEPTOR BLOCKADE IN CIRRHOTIC RATS WITH ASCITES [J].
ANGELI, P ;
JIMENEZ, W ;
ARROYO, V ;
MACKENZIE, HS ;
ZHANG, PL ;
CLARIA, J ;
RIVERA, F ;
BRENNER, BM ;
RODES, J .
HEPATOLOGY, 1994, 20 (04) :948-954
[8]   TUBULAR SITE OF RENAL SODIUM RETENTION IN ASCITIC LIVER-CIRRHOSIS EVALUATED BY LITHIUM CLEARANCE [J].
ANGELI, P ;
GATTA, A ;
CAREGARO, L ;
MENON, F ;
SACERDOTI, D ;
MERKEL, C ;
RONDANA, M ;
DETONI, R ;
RUOL, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (01) :111-117
[9]  
Angeli P, 1996, HEPATOLOGY, V23, P264
[10]  
Arroyo JLB, 2000, J PRAGMATICS, V32, P1